Veterinary CRO And CDMO Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends
Overview and Scope
A veterinary CRO is
a specialized service provider that conducts research and clinical trials to
evaluate the safety and efficacy of veterinary drugs and healthcare products,
and a veterinary CDMO is a specialized service provider that offers contract development
and manufacturing services for veterinary drugs and healthcare products,
assisting with formulation development, process optimization, and production.
Sizing and Forecast
The veterinary cro and cdmo market size has grown strongly in recent years.
It will grow from $6.44 billion in 2023 to $7.03 billion in 2024 at a compound
annual growth rate (CAGR) of 9.1%.
The growth in the historic period
can be attributed to regulatory compliance needs, globalization of animal
health market, increased drug development for livestock, increased outsourcing
by pharma companies.
The veterinary cro and cdmo market size is expected to see strong growth in the
next few years. It will grow to $9.87 billion in 2028 at a compound annual
growth rate (CAGR) of 8.9%. The growth
in the forecast period can be attributed to increasing adoption of precision
medicine, focus on preventive healthcare, epidemiological surveillance,
emergency preparedness, increasing complexity of veterinary therapeutics. Major
trends in the forecast period include outsourcing of research and development,
integration of technology, collaborations and partnerships, sustainability in
manufacturing, digitalization of veterinary services.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report
Segmentation & Regional Insights
The veterinary cro and cdmo market covered in this report is segmented –
1) By Service Type:
Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval
And Post-marketing
2) By Animal Type: Companion Animals, Livestock Animals
3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics,
Other Applications
North America was the largest region in the veterinary CRO and CDMO
market in 2023. Asia-Pacific is expected to be the fastest-growing region
in the forecast period. The regions covered in the veterinary cro and cdmo
market report are Asia-Pacific, Western Europe, Eastern Europe, North America,
South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the
report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp
Major Driver Impacting Market Growth
Increasing animal healthcare investments is expected to propel the growth
of the veterinary CRO and CDMO market going forward. Investments in animal
healthcare have been increasing in recent years due to the growing awareness of
the importance of animal health and the expanding demand for veterinary
services and products, hence contributing to the growth of the veterinary CRO
and CDMO market. For Instance, in 2022, according to the report published by
the American Pet Products Association (APPA), a US-based non-profit
organization that promotes, develops, and advances pet ownership and the pet
products industry, pet care expenditure in the U.S. increased from USD 123.6
billion in 2021 to 136.8 billion in 2022. Therefore, increasing animal
healthcare investments will drive the veterinary CRO and CDMO market growth.
Key Industry Players
Major companies operating in the veterinary cro and cdmo market report are
Labcorp Drug Development India Private Limited, Zoetis Inc., Eurofins
Scientific SE, Pharmaceutical Product Development Inc., Syneos Health Inc.,
Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private
Limited., Inotiv Inc., Promega Corporation, Aenova Group, Sai Life Sciences
Ltd., Taconic Bioscience Inc., Avid Bioservices Inc., Frontage Laboratories
Inc., Angion Biomedica Corp., knoell Germany GmbH, ClinVet International Pty
Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd.,
Drayton Animal Health Ltd., KLIFOVET GmbH, Triveritas Ltd., Cebiphar, Ondax
Scientific UK Ltd., Veterinary Research Management (VRM) Ltd., Vetspin Srl,
STATKING Animal Health CRO, Arcoblu S.r.l.
The veterinary cro and cdmo market report table of contents includes:
1. Executive Summary
2. Veterinary CRO And CDMO Market Characteristics
3. Veterinary CRO And CDMO Market Trends And Strategies
4. Veterinary CRO And CDMO Market - Macro Economic Scenario
5. Global Veterinary CRO And CDMO Market Size and Growth
…………..
32. Global Veterinary CRO And CDMO Market Competitive Benchmarking33. Global Veterinary CRO And CDMO Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Veterinary CRO And CDMO Market
35. Veterinary CRO And CDMO Market Future Outlook and Potential Analysis
36. Appendix
Comments
Post a Comment